Essential Thrombocythemia (ET)
''Essential thrombocytosis (primary thrombocythemia), first described by Epstein and Goedel in 1934, is a nonreactive, chronic myeloproliferative disorder.
Essential thrombocytosis (primary thrombocythemia) is associated with sustained megakaryocyte proliferation that increases the number of circulating platelets. Traditionally, essential thrombocytosis (primary thrombocythemia) was considered a clonal disorder that involved pluripotent stem cells; however, studies have indicated that some patients may have polyclonal hematopoiesis''
Extract of Medscape
Sites
Essential thrombocythemia by Genetics Home Reference
Essential thrombocythemia by CNNHealth
Essential thrombocythemia by Mayo Clinic
Essential thrombocythemia by Genetics Home Reference
Essential thrombocythemia by CNNHealth
Essential thrombocythemia by Mayo Clinic
Videos
Essential Thrombocythemia Updates 2012 – Mayo Clinic
March 15, 2012, Mayo Clinic
Essential Thrombocythemia (2009) - Mayo Clinic
December 4, 2009, Mayo Clinic
Essential Thrombocythemia Updates 2012 – Mayo Clinic
March 15, 2012, Mayo Clinic
Essential Thrombocythemia (2009) - Mayo Clinic
December 4, 2009, Mayo Clinic
Articles
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
March 2012,PubLMed
Pregnancy and essential thrombocytemia
March 29, 2011, PublMed Central
New Advances in the Pathogenesis and Therapy of Essential Thrombocythemia
January 1, 2008, Hematology
Essential thrombocythemia (Pr Jean Brière – France)
January 8, 2007, PublMed Central
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
March 2012,PubLMed
Pregnancy and essential thrombocytemia
March 29, 2011, PublMed Central
New Advances in the Pathogenesis and Therapy of Essential Thrombocythemia
January 1, 2008, Hematology
Essential thrombocythemia (Pr Jean Brière – France)
January 8, 2007, PublMed Central
Disclaimer:
We accept no responsibility for and make no representations or warranties regarding the content of the information presented. Access to and use of the information herein is entirely at the risk of the user.
